Chemours (CC) Expected to Announce Earnings on Tuesday

Key Points

• Chemours is set to release its Q2 2025 earnings on August 5th, with analysts expecting earnings of $0.47 per share and $1.57 billion in revenue.
• The company's shares recently fell 7.6%, trading at $12.56, and it has a market capitalization of $1.88 billion.
• Insider transactions include significant stock purchases by CFO Shane Hostetter and other insiders, indicating confidence in the company's future performance.

Chemours (NYSE:CC - Get Free Report) is projected to issue its Q2 2025 quarterly earnings data after the market closes on Tuesday, August 5th. Analysts expect Chemours to post earnings of $0.47 per share and revenue of $1.57 billion for the quarter.

Chemours (NYSE:CC - Get Free Report) last announced its earnings results on Tuesday, May 6th. The specialty chemicals company reported $0.13 earnings per share for the quarter, missing the consensus estimate of $0.19 by ($0.06). Chemours had a return on equity of 23.82% and a net margin of 0.54%. The business had revenue of $1.37 billion for the quarter, compared to analyst estimates of $1.36 billion. During the same period in the previous year, the company earned $0.32 earnings per share. The company's quarterly revenue was up .4% compared to the same quarter last year. On average, analysts expect Chemours to post $2 EPS for the current fiscal year and $3 EPS for the next fiscal year.

Chemours Price Performance

NYSE CC traded down $0.48 during mid-day trading on Friday, hitting $11.50. The stock had a trading volume of 2,415,632 shares, compared to its average volume of 3,456,204. The firm's 50 day moving average is $12.00 and its 200 day moving average is $13.59. Chemours has a twelve month low of $9.13 and a twelve month high of $22.38. The company has a debt-to-equity ratio of 7.01, a current ratio of 1.75 and a quick ratio of 0.83. The stock has a market capitalization of $1.72 billion, a price-to-earnings ratio of 57.51 and a beta of 1.65.

Chemours Announces Dividend

The business also recently disclosed a dividend, which was paid on Monday, June 16th. Stockholders of record on Monday, May 19th were paid a $0.0875 dividend. This represents a dividend yield of 317.0%. The ex-dividend date was Friday, May 16th. Chemours's dividend payout ratio (DPR) is presently 175.00%.

Wall Street Analyst Weigh In

A number of analysts have commented on CC shares. Wall Street Zen downgraded Chemours from a "hold" rating to a "sell" rating in a research report on Wednesday, May 21st. UBS Group dropped their target price on Chemours from $18.00 to $17.00 and set a "buy" rating for the company in a research note on Wednesday, May 7th. Morgan Stanley dropped their price target on Chemours from $22.00 to $15.00 and set an "equal weight" rating for the company in a research note on Monday, May 12th. Mizuho upped their target price on Chemours from $13.00 to $16.00 and gave the stock an "outperform" rating in a research report on Tuesday, July 15th. Finally, Royal Bank Of Canada increased their price target on Chemours from $14.00 to $15.00 and gave the company an "outperform" rating in a report on Thursday, July 3rd. One analyst has rated the stock with a sell rating, four have given a hold rating and five have issued a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of "Hold" and an average target price of $17.44.

Insider Buying and Selling at Chemours

In related news, insider Damian Gumpel purchased 13,400 shares of the business's stock in a transaction on Monday, June 2nd. The stock was acquired at an average price of $9.22 per share, for a total transaction of $123,548.00. Following the purchase, the insider owned 123,879 shares of the company's stock, valued at approximately $1,142,164.38. This trade represents a 12.13% increase in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which can be accessed through this hyperlink. Also, CFO Shane Hostetter acquired 4,450 shares of Chemours stock in a transaction on Monday, May 19th. The stock was purchased at an average cost of $11.28 per share, with a total value of $50,196.00. Following the completion of the transaction, the chief financial officer directly owned 59,694 shares in the company, valued at $673,348.32. This represents a 8.06% increase in their position. The disclosure for this purchase can be found here. In the last 90 days, insiders purchased 25,672 shares of company stock worth $251,573. 0.47% of the stock is owned by company insiders.

Institutional Investors Weigh In On Chemours

A number of institutional investors have recently added to or reduced their stakes in CC. Baird Financial Group Inc. bought a new stake in Chemours in the 1st quarter valued at about $148,000. Royal Bank of Canada boosted its holdings in Chemours by 6.8% in the 1st quarter. Royal Bank of Canada now owns 585,702 shares of the specialty chemicals company's stock worth $7,926,000 after buying an additional 37,382 shares during the period. AQR Capital Management LLC bought a new position in Chemours in the 1st quarter worth approximately $161,000. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. boosted its holdings in Chemours by 149.3% in the 1st quarter. MIRAE ASSET GLOBAL ETFS HOLDINGS Ltd. now owns 43,243 shares of the specialty chemicals company's stock worth $593,000 after buying an additional 25,899 shares during the period. Finally, Empowered Funds LLC bought a new position in Chemours in the 1st quarter worth approximately $403,000. 76.26% of the stock is owned by institutional investors.

Chemours Company Profile

The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through three segments: Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. The Titanium Technologies segment provides TiO2 pigment under the Ti-Pure brand for delivering whiteness, brightness, opacity, durability, efficiency, and protection in various of applications, such as architectural and industrial coatings, flexible and rigid plastic packaging, polyvinylchloride, laminate papers used for furniture and building materials, coated paper, and coated paperboard used for packaging.